{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:42:05Z","timestamp":1784241725595,"version":"3.55.0"},"reference-count":104,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Endometrial cancer (EC) is the most common gynecological tumor in developed countries, and presents a wide variety of histological and molecular characteristics that make its treatment increasingly complex. In recent years, advances in molecular imaging, particularly with [18F]FDG-PET\/CT and PET\/MRI, have changed clinicians\u2019 management of diagnosis, treatment planning, and prognosis of EC. Methods: In this narrative review, a search was conducted for current evidence on the role of [18F]FDG-PET\/CT and PET\/MRI throughout the treatment of EC, focusing on their diagnostic performance, clinical relevance, and prognostic implications. Their use in areas such as initial staging, treatment monitoring, recurrence detection, and individualized risk assessment was also discussed. Results: [18F]FDG-PET\/CT is effective in detecting lymph node and distant metastases, while [18F]FDG-PET\/MRI offers greater accuracy for T and N staging. In addition, [18F]FDG-PET\/CT provides early metabolic indicators of therapeutic response and facilitates differentiation between viable tumors and post-treatment changes. Radiomics-derived parameters have shown promising associations with tumor aggressiveness and lymphovascular invasion and survival, supporting their role as prognostic imaging biomarkers. In addition, the use of non-FDG radiotracers, as well as predictive models based on machine learning, can further refine preoperative stratification and treatment planning in certain subtypes of EC. Conclusions: Molecular imaging enhances the accuracy of TNM staging in EC. The incorporation of molecular imaging biomarkers into daily clinical practice could significantly improve personalized decision-making in EC. However, large prospective studies are needed to confirm their efficacy.<\/jats:p>","DOI":"10.3390\/cancers17162608","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:30:52Z","timestamp":1754667052000},"page":"2608","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular Imaging in Endometrial Cancer: A Narrative Review"],"prefix":"10.3390","volume":"17","author":[{"given":"Ana Mar\u00eda","family":"Garc\u00eda-Vicente","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, University Hospital of Toledo, 45007 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Perlaza-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Nuclear Medicine-PET (ICS-IDI) Department, Bellvitge University Hospital, L\u2019Hospitalet de Llobregat, 08907 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan\u00eda Aida","family":"Guzm\u00e1n-Ortiz","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University Hospital of Toledo, 45007 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-063X","authenticated-orcid":false,"given":"Marta","family":"Tormo-Ratera","sequence":"additional","affiliation":[{"name":"Nuclear Medicine-PET (ICS-IDI) Department, Bellvitge University Hospital, L\u2019Hospitalet de Llobregat, 08907 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"S\u00e1nchez-M\u00e1rquez","sequence":"additional","affiliation":[{"name":"Radiology Department, Bellvitge University Hospital, L\u2019Hospitalet de Llobregat, 08907 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Cort\u00e9s-Romera","sequence":"additional","affiliation":[{"name":"Nuclear Medicine-PET (ICS-IDI) Department, Bellvitge University Hospital, L\u2019Hospitalet de Llobregat, 08907 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2725-8920","authenticated-orcid":false,"given":"Edel","family":"Noriega-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Guadalajara, 19002 Guadalajara, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1148\/rg.220070","article-title":"Update on MRI in Evaluation and Treatment of Endometrial Cancer","volume":"42","author":"Maheshwari","year":"2022","journal-title":"Radiographics"},{"key":"ref_2","unstructured":"Kurman, R.J., Carcangiu, M.L., Herrington, C.S., and Young, R.H. (2014). WHO Classification of Tumours of Female Reproductive Organs, International Agency for Research on Cancer. [4th ed.]. World Health Organization Classification of Tumours."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO Staging of Endometrial Cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-Up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP Guidelines for the Management of Patients with Endometrial Carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2017.10.037","article-title":"An NRG Oncology\/GOG Study of Molecular Classification for Risk Prediction in Endometrioid Endometrial Cancer","volume":"148","author":"Cosgrove","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_7","first-page":"258","article-title":"Current Recommendations and Recent Progress in Endometrial Cancer","volume":"69","author":"Brooks","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/cam4.4486","article-title":"Preoperative Magnetic Resonance Imaging Predicts Clinicopathological Parameters and Stages of Endometrial Carcinomas","volume":"11","author":"Wu","year":"2022","journal-title":"Cancer Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4274\/nts.galenos.2022.0019","article-title":"PET Imaging of Endometrial Cancer","volume":"8","author":"Civan","year":"2022","journal-title":"Nucl. Med. Semin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_11","first-page":"e80109","article-title":"The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET\/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis","volume":"17","author":"Shibuya","year":"2025","journal-title":"Cureus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ygyno.2014.01.039","article-title":"Risk Stratification and Prognosis Determination Using (18)F-FDG PET Imaging in Endometrial Cancer Patients: A Systematic Review and Meta-Analysis","volume":"132","author":"Ghooshkhanei","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00330-019-06622-w","article-title":"Preoperative 18F-FDG PET\/CT Tumor Markers Outperform MRI-Based Markers for the Prediction of Lymph Node Metastases in Primary Endometrial Cancer","volume":"30","author":"Fasmer","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00330-022-08949-3","article-title":"Preoperative Pelvic MRI and 2-[18F]FDG PET\/CT for Lymph Node Staging and Prognostication in Endometrial Cancer-Time to Revisit Current Imaging Guidelines?","volume":"33","author":"Fasmer","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e7081","DOI":"10.7717\/peerj.7081","article-title":"Comparison of Integrated PET\/MRI with PET\/CT in Evaluation of Endometrial Cancer: A Retrospective Analysis of 81 Cases","volume":"7","author":"Bian","year":"2019","journal-title":"PeerJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/RLU.0000000000004064","article-title":"Hybrid PET\/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort","volume":"47","author":"Ironi","year":"2022","journal-title":"Clin. Nucl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yu, Y., Zhang, L., Sultana, B., Wang, B., and Sun, H. (2022). Diagnostic Value of Integrated 18F-FDG PET\/MRI for Staging of Endometrial Carcinoma: Comparison with PET\/CT. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10037-0"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.ejrad.2013.05.005","article-title":"Value of Fusion of PET and MRI for Staging of Endometrial Cancer: Comparison with 18 F-FDG Contrast-Enhanced PET\/CT and Dynamic Contrast-Enhanced Pelvic MRI","volume":"82","author":"Kitajima","year":"2013","journal-title":"Eur. J. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40336-021-00463-8","article-title":"18F-FDG PET\/MRI in Endometrial Cancer: Systematic Review and Meta-Analysis","volume":"10","author":"Bezzi","year":"2022","journal-title":"Clin. Transl. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vahidfar, N., Farzanefar, S., Ahmadzadehfar, H., Molloy, E.N., and Eppard, E. (2022). A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies. Cancers, 14.","DOI":"10.3390\/cancers14071779"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Yashar","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12094-022-02799-7","article-title":"SEOM-GEICO Clinical Guidelines on Endometrial Cancer (2021)","volume":"24","author":"Esteban","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s00259-020-05112-2","article-title":"EANM\/SNMMI Practice Guideline for [18F]FDG PET\/CT External Beam Radiotherapy Treatment Planning in Uterine Cervical Cancer v1.0","volume":"48","author":"Adam","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3802\/jgo.2025.36.e25","article-title":"Is Presumed Clinical Stage I Endometrial Cancer Using PET-CT and MRI Accurate in Predicting Surgical Staging?","volume":"36","author":"Seon","year":"2025","journal-title":"J. Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13244-019-0696-8","article-title":"Role of MRI in Staging and Follow-up of Endometrial and Cervical Cancer: Pitfalls and Mimickers","volume":"10","author":"Nikolic","year":"2019","journal-title":"Insights Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/RLU.0000000000000852","article-title":"Staging of High-Risk Endometrial Cancer With PET\/CT and Sentinel Lymph Node Mapping","volume":"40","author":"Signorelli","year":"2015","journal-title":"Clin. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Weissinger, M., Bala, L., Brucker, S.Y., Kommoss, S., Hoffmann, S., Seith, F., Nikolaou, K., la Foug\u00e8re, C., Walter, C.B., and Dittmann, H. (2024). Additional Value of FDG-PET\/MRI Complementary to Sentinel Lymphonodectomy for Minimal Invasive Lymph Node Staging in Patients with Endometrial Cancer: A Prospective Study. Diagnostics, 14.","DOI":"10.3390\/diagnostics14040376"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"\u015eahin, G., Haz\u0131rBulan, A., S\u00f6zen, I., Kocadal, N.\u00c7., Alk\u0131\u015f, \u0130., Yard\u0131mc\u0131, A.H., Akka\u015f, B.E., and Arslan, H.S. (2025). Optimizing Final Pathology Determination in Endometrial Cancer: The Role of PET\/CT, MRI, and Biopsy in Serous, Mixed Cell, Clear Cell, and Grade 3 Endometrioid Subtypes. Diagnostics, 15.","DOI":"10.3390\/diagnostics15060731"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Restaino, S., Paglietti, C., Arcieri, M., Biasioli, A., Della Martina, M., Mariuzzi, L., Andreetta, C., Titone, F., Bogani, G., and Raimondo, D. (2023). Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines. Cancers, 15.","DOI":"10.3390\/cancers15041091"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/IGC.0000000000001076","article-title":"Clinical Utility of Preoperative Computed Tomography in Patients With Endometrial Cancer","volume":"27","author":"Bogani","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100698","DOI":"10.1016\/j.gore.2021.100698","article-title":"Detection of Bone Metastases in Uterine Cancer: How Common Are They and Should PET\/CT Be the Standard for Diagnosis?","volume":"35","author":"Hong","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40644-020-00357-4","article-title":"Diagnostic Value of 18F-FDG PET\/MRI for Staging in Patients with Endometrial Cancer","volume":"20","author":"Tsuyoshi","year":"2020","journal-title":"Cancer Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ijgc-2021-002460","article-title":"Imaging to Optimize Gynecological Radiation Oncology","volume":"32","author":"Kidd","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/ijgc-2020-001822","article-title":"Adjuvant Therapy for Endometrial Cancer in the Era of Molecular Classification: Radiotherapy, Chemoradiation and Novel Targets for Therapy","volume":"31","author":"Horeweg","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the Corpus Uteri: 2021 Update","volume":"155","author":"Koskas","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2022.02.001","article-title":"Variation in Practice in Endometrial Cancer and Potential for Improved Care and Equity through Molecular Classification","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.rcl.2023.02.012","article-title":"Image-Guided Radiotherapy for Gynecologic Malignancies: What the Radiologist Needs to Know","volume":"61","author":"Jacobsen","year":"2023","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_38","first-page":"e2274","article-title":"Brachy-Ing Unresectable Endometrial Cancers with Magnetic Resonance Guidance","volume":"10","author":"Conway","year":"2018","journal-title":"Cureus"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Collarino, A., Vidal-Sicart, S., and Vald\u00e9s Olmos, R.A. (2022). Nuclear Medicine Manual on Gynaecological Cancers and Other Female Malignancies, Springer International Publishing.","DOI":"10.1007\/978-3-031-05497-6"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/GCO.0b013e32835a7e96","article-title":"FDG PET\/CT in Monitoring Response to Treatment in Gynecological Malignancies","volume":"25","author":"Amit","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2214\/AJR.10.4562","article-title":"Skeletal Scintigraphy in Pediatric Sports Medicine","volume":"195","author":"Zukotynski","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00259-007-0627-7","article-title":"Monitoring the Neoadjuvant Therapy Response in Gynecological Cancer Patients Using FDG PET","volume":"35","author":"Nishiyama","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ygyno.2013.06.021","article-title":"Prognostic Value of Preoperative Metabolic Tumor Volume Measured by 18F-FDG PET\/CT and MRI in Patients with Endometrial Cancer","volume":"130","author":"Chung","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cpet.2017.11.006","article-title":"FDG-PET Assessment of Other Gynecologic Cancers","volume":"13","author":"Faria","year":"2018","journal-title":"PET Clin."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cpet.2017.11.010","article-title":"Quantitative Assessment of Gynecologic Malignancies","volume":"13","author":"Tripathy","year":"2018","journal-title":"PET Clin."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.semnuclmed.2024.01.003","article-title":"Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review","volume":"54","author":"Khessib","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial Cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crad.2006.06.015","article-title":"Recurrent Endometrial Cancer: Patterns of Recurrent Disease and Assessment of Prognosis","volume":"62","author":"Sohaib","year":"2007","journal-title":"Clin. Radiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1102\/1470-7330.2013.0011","article-title":"Typical and Atypical Metastatic Sites of Recurrent Endometrial Carcinoma","volume":"13","author":"Kurra","year":"2013","journal-title":"Cancer Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygyno.2012.10.022","article-title":"Accuracy of 18-F-FDG PET Imaging in the Follow up of Endometrial Cancer Patients: Systematic Review and Meta-Analysis of the Literature","volume":"128","author":"Kadkhodayan","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Nie, J., Zhang, J., Gao, J., Guo, L., Zhou, H., Hu, Y., Zhu, C., Li, Q., and Ma, X. (2017). Diagnostic Role of 18F-FDG PET\/MRI in Patients with Gynecological Malignancies of the Pelvis: A Systematic Review and Meta-Analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175401"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Kirchner, J., Sawicki, L.M., Suntharalingam, S., Grueneisen, J., Ruhlmann, V., Aktas, B., Deuschl, C., Herrmann, K., Antoch, G., and Forsting, M. (2017). Whole-Body Staging of Female Patients with Recurrent Pelvic Malignancies: Ultra-Fast 18F-FDG PET\/MRI Compared to 18F-FDG PET\/CT and CT. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172553"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/MNM.0000000000000839","article-title":"Diagnostic Value of 18F-FDG PET\/MRI in Recurrent Pelvis Malignancies of Female Patients: A Systematic Review and Meta-Analysis","volume":"39","author":"Zheng","year":"2018","journal-title":"Nucl. Med. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00259-005-1876-y","article-title":"18F-FDG PET in the Management of Endometrial Cancer","volume":"33","author":"Chao","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00259-017-3881-3","article-title":"Comparison of 18F\u2013FDG PET\/MRI and MRI Alone for Whole-Body Staging and Potential Impact on Therapeutic Management of Women with Suspected Recurrent Pelvic Cancer: A Follow-up Study","volume":"45","author":"Sawicki","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00330-015-3657-8","article-title":"PET\/MRI and PET\/CT in Advanced Gynaecological Tumours: Initial Experience and Comparison","volume":"25","author":"Queiroz","year":"2015","journal-title":"Eur. Radiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00259-002-0878-2","article-title":"Usefulness of 18F-FDG PET in the Post-Therapy Surveillance of Endometrial Carcinoma","volume":"29","author":"Belhocine","year":"2002","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1525-1438.2008.01197.x","article-title":"Clinical Impact of Positron Emission Tomography or Positron Emission Tomography\/Computed Tomography in the Posttherapy Surveillance of Endometrial Carcinoma: Evaluation of 88 Patients","volume":"18","author":"Park","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cpet.2017.11.011","article-title":"Emerging Molecular Imaging Techniques in Gynecologic Oncology","volume":"13","author":"Lin","year":"2018","journal-title":"PET Clin."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00006231-200606000-00002","article-title":"FDG PET for the Assessment of Myometrial Infiltration in Clinical Stage I Uterine Corpus Cancer","volume":"27","author":"Torizuka","year":"2006","journal-title":"Nucl. Med. Commun."},{"key":"ref_61","first-page":"748","article-title":"SUVmax measured by 18F FDG PET\/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer","volume":"84","author":"Walentowicz","year":"2013","journal-title":"Ginekol. Pol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00259-014-2964-7","article-title":"FDG PET\/CT Diagnostic Criteria May Need Adjustment Based on MRI to Estimate the Presurgical Risk of Extrapelvic Infiltration in Patients with Uterine Endometrial Cancer","volume":"42","author":"Sudo","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ijgc-2019-000945","article-title":"Combining Positron Emission Tomography\/Computed Tomography, Radiomics, and Sentinel Lymph Node Mapping for Nodal Staging of Endometrial Cancer Patients","volume":"30","author":"Crivellaro","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/MNM.0000000000001091","article-title":"Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis Assessed by 18F-FDG PET\/CT in Endometrial Cancer","volume":"40","author":"Erdogan","year":"2019","journal-title":"Nucl. Med. Commun."},{"key":"ref_65","first-page":"3","article-title":"Prognostic Role of FDG PET-Derived Parameters in Preoperative Staging of Endometrial Cancer","volume":"38","author":"Mapelli","year":"2019","journal-title":"Rev. Espa\u00f1ola Med. Nucl. Imagen Mol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ygyno.2022.03.009","article-title":"The Immunohistochemical Molecular Risk Classification in Endometrial Cancer: A Pragmatic and High-Reproducibility Method","volume":"165","author":"Perrone","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3413\/nukmed-0375-10-12","article-title":"Preoperative Risk Stratification Using (18)F-FDG PET\/CT in Women with Endometrial Cancer","volume":"50","author":"Lee","year":"2011","journal-title":"Nuklearmedizin"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5603\/GP.2016.0032","article-title":"Prognostic Value of 18F-FDG PET\/CT for Identifying High- and Low-Risk Endometrial Cancer Patients","volume":"87","author":"Erkaya","year":"2016","journal-title":"Ginekol. Pol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00259-015-3037-2","article-title":"Preoperative Risk Stratification Using Metabolic Parameters of (18)F-FDG PET\/CT in Patients with Endometrial Cancer","volume":"42","author":"Kitajima","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.acra.2023.08.012","article-title":"PET\/MRI in Endometrial Cancer: Imaging Biomarkers Are Associated with Disease Progression and Overall Survival","volume":"31","author":"Shih","year":"2024","journal-title":"Acad. Radiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00259-012-2240-7","article-title":"The Preoperative SUVmax Is Superior to ADCmin of the Primary Tumour as a Predictor of Disease Recurrence and Survival in Patients with Endometrial Cancer","volume":"40","author":"Nakamura","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ygyno.2012.03.021","article-title":"Metabolic Tumor Volume by 18F-FDG PET\/CT Is Prognostic for Stage IVB Endometrial Carcinoma","volume":"125","author":"Liu","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00259-011-2057-9","article-title":"Prognostic Significance of SUVmax (Maximum Standardized Uptake Value) Measured by [18F]FDG PET\/CT in Endometrial Cancer","volume":"39","author":"Kitajima","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.5603\/GP.2019.0085","article-title":"Prognostic Role of PET\/CT in Endometrial Cancer","volume":"90","author":"Budak","year":"2019","journal-title":"Ginekol. Pol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1471-0528.12543","article-title":"Metabolic Tumour Volume and Total Lesion Glycolysis, Measured Using Preoperative 18F-FDG PET\/CT, Predict the Recurrence of Endometrial Cancer","volume":"121","author":"Shim","year":"2014","journal-title":"BJOG Int. J. Obstet. Gynecol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13139-013-0228-2","article-title":"Prognostic Value of Metabolic Activity Measured by (18)F-FDG PET\/CT in Patients with Advanced Endometrial Cancer","volume":"47","author":"Kim","year":"2013","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00259-017-3805-2","article-title":"Prognostic Value of Lymph Node-to-Primary Tumor Standardized Uptake Value Ratio in Endometrioid Endometrial Carcinoma","volume":"45","author":"Chung","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_78","first-page":"24","article-title":"A Systematic Review about the Role of Preoperative 18F-FDG PET\/CT for Prognosis and Risk Stratification in Patients with Endometrial Cancer","volume":"42","year":"2023","journal-title":"Rev. Espa\u00f1ola Med. Nucl. Imagen Mol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00259-010-1589-8","article-title":"Functional Oestrogen Receptor \u03b1 Imaging in Endometrial Carcinoma Using 16\u03b1-[18F]Fluoro-17\u03b2-Oestradiol PET","volume":"38","author":"Tsujikawa","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2967\/jnumed.112.113472","article-title":"18F-FES and 18F-FDG PET for Differential Diagnosis and Quantitative Evaluation of Mesenchymal Uterine Tumors: Correlation with Immunohistochemical Analysis","volume":"54","author":"Zhao","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nucmedbio.2005.11.002","article-title":"Automatic Synthesis of 16\u03b1-[18F]Fluoro-17\u03b2-Estradiol Using a Cassette-Type [18F]Fluorodeoxyglucose Synthesizer","volume":"33","author":"Mori","year":"2006","journal-title":"Nucl. Med. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2083::AID-CNCR28>3.0.CO;2-2","article-title":"Estrogen Receptor Status, Determined by Immunohistochemistry, as a Predictor of the Recurrence of Stage I Endometrial Carcinoma","volume":"86","author":"Gehrig","year":"1999","journal-title":"Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2008.10.032","article-title":"Expression of Estrogen Receptor-Alpha and -Beta and Progesterone Receptor-A and -B in a Large Cohort of Patients with Endometrioid Endometrial Cancer","volume":"112","author":"Jongen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1016\/j.ejca.2013.06.016","article-title":"Hormone Receptor Loss in Endometrial Carcinoma Curettage Predicts Lymph Node Metastasis and Poor Outcome in Prospective Multicentre Trial","volume":"49","author":"Trovik","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2967\/jnumed.120.244319","article-title":"Prognostic Value of 16\u03b1-18F-Fluoro-17\u03b2-Estradiol PET as a Predictor of Disease Outcome in Endometrial Cancer: A Prospective Study","volume":"62","author":"Yamada","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1148\/radiol.2482071379","article-title":"Uterine Tumors: Pathophysiologic Imaging with 16alpha-[18F]Fluoro-17beta-Estradiol and 18F Fluorodeoxyglucose PET--Initial Experience","volume":"248","author":"Tsujikawa","year":"2008","journal-title":"Radiology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2967\/jnumed.108.060145","article-title":"Functional Images Reflect Aggressiveness of Endometrial Carcinoma: Estrogen Receptor Expression Combined with 18F-FDG PET","volume":"50","author":"Tsujikawa","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"22581","DOI":"10.18632\/oncotarget.15127","article-title":"18F-FDG\/18F-FES Standardized Uptake Value Ratio Determined Using PET Predicts Prognosis in Uterine Sarcoma","volume":"8","author":"Yamamoto","year":"2017","journal-title":"Oncotarget"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.ejca.2013.08.005","article-title":"Positron Emission Tomography Imaging of Oestrogen Receptor-Expression in Endometrial Stromal Sarcoma Supports Oestrogen Receptor-Targeted Therapy: Case Report and Review of the Literature","volume":"49","author":"Hospers","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0969-8051(97)00002-4","article-title":"Analysis of Blood Clearance and Labeled Metabolites for the Estrogen Receptor Tracer [F-18]-16 Alpha-Fluoroestradiol (FES)","volume":"24","author":"Mankoff","year":"1997","journal-title":"Nucl. Med. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0969-8051(99)00072-4","article-title":"Interactions of 16alpha-[18F]-Fluoroestradiol (FES) with Sex Steroid Binding Protein (SBP)","volume":"26","author":"Tewson","year":"1999","journal-title":"Nucl. Med. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1039\/b110021c","article-title":"Synthesis of 2,16\u03b1- and 4,16\u03b1-Difluoroestradiols and Their 11\u03b2-Methoxy Derivatives as Potential Estrogen Receptor-Binding Radiopharmaceuticals","volume":"44","author":"Seimbille","year":"2002","journal-title":"J. Chem. Soc. Perkin Trans. 1"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0039-128X(02)00025-9","article-title":"18F-Labeled Difluoroestradiols: Preparation and Preclinical Evaluation as Estrogen Receptor-Binding Radiopharmaceuticals","volume":"67","author":"Seimbille","year":"2002","journal-title":"Steroids"},{"key":"ref_94","first-page":"702","article-title":"18 F-4FMFES and 18F-FDG PET\/CT in ER+ Endometrial Carcinomas: Preliminary Report","volume":"63","author":"Paquette","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in Patients with Various Gynecological Malignancies","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Li, T., Zhang, J., Yan, Y., Tan, M., and Chen, Y. (2024). Applications of FAPI PET\/CT in the Diagnosis and Treatment of Breast and the Most Common Gynecologic Malignancies: A Literature Review. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1358070"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MNM.0000000000001977","article-title":"The Role of 68Ga-FAPI PET\/CT Imaging in Gynecological Cancers: An Integrative Review","volume":"46","author":"Usmani","year":"2025","journal-title":"Nucl. Med. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.7150\/jca.39423","article-title":"Preoperative Evaluation of Residual Tumor in Patients with Endometrial Carcinoma by Using 18F-FDG PET\/CT","volume":"11","author":"Wu","year":"2020","journal-title":"J. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/RLU.0000000000004532","article-title":"18F-FDG and 68Ga-FAPI-04 PET\/CT in Evaluating Clear-Cell Endometrial Cancer","volume":"48","author":"Kiran","year":"2023","journal-title":"Clin. Nucl. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12149-012-0597-0","article-title":"18F-FLT PET Performs Better than 18F-FDG PET in Differentiating Malignant Uterine Corpus Tumors from Benign Leiomyoma","volume":"26","author":"Yamane","year":"2012","journal-title":"Ann. Nucl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ajpath.2024.05.003","article-title":"Deep Learning for Grading Endometrial Cancer","volume":"194","author":"Goyal","year":"2024","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Bezzi, C., Bergamini, A., Mathoux, G., Ghezzo, S., Monaco, L., Candotti, G., Fallanca, F., Gajate, A.M.S., Rabaiotti, E., and Cioffi, R. (2023). Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness. Cancers, 15.","DOI":"10.3390\/cancers15010325"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s42256-023-00633-5","article-title":"Multimodal data fusion for cancer biomarker discovery with deep learning","volume":"5","author":"Steyaert","year":"2023","journal-title":"Nat. Mach. Intell."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2608\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:51Z","timestamp":1760034411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":104,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["cancers17162608"],"URL":"https:\/\/doi.org\/10.3390\/cancers17162608","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}